Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Long-Term Safety Follow-up of a Randomized Trial of Darbepoetin Alpha and Intravenous Iron Following Autologous Hematopoietic Cell Transplantation

Aurélie Jaspers, MD, Frederic Baron, MD PhD, Johan Maertens, MD PhD, Bernard J. M. De Prijck, MD, Henri (Rik) Schots, MDPhD, Christophe Bonnet, MD PhD, Kaoutar Hafraoui, MD, Evelyne Willems, MD PhD, Sophie Servais, MD PhD, Georges Fillet, MD PhD, Yves Beguin, MD PhD

Blood (2014) 124 (21): 3948.

https://doi.org/10.1182/blood.V124.21.3948.3948

Published: 2014

Journal Articles

High Dose (HD-AraC) Vs Standard Dose Cytosine Arabinoside (SD-AraC) During Induction and IL-2 Vs Observation After Consolidation/Autologous Stem Cell Transplantation in Patients with Acute Myelogenous Leukemia (AML): Final Report of the AML-12 Trial of EORTC and GIMEMA Leukemia Groups on the Value of High Dose AraC

Blood (2011) 118 (21): 257.

https://doi.org/10.1182/blood.V118.21.257.257

Published: 2011

Journal Articles

High Dose (HD-AraC) Vs Standard Dose Cytosine Arabinoside (SDAraC) during Induction and Value of IL-2 during Maintenance in Acute Myelogenous Leukemia (AML): Impact of AraC Dose on Complete Remission Rate and Toxicity (Results on the first 1700 randomized patients of the AML-12 trial of EORTC and GIMEMA Leukemia Groups)

Blood (2008) 112 (11): 134.

https://doi.org/10.1182/blood.V112.11.134.134

Published: 2008

Journal Articles

Darbepoetin-Alfa and I.V. Iron Administration after Autologous Hematopoietic Stem Cell Transplantation: A Prospective Randomized Multicenter Trial

Yves Beguin, Johan Maertens, Bernard De Prijck, Rik Schots, MD, Pascale Frere, Christophe Bonnet, Kaoutar Hafraoui, Evelyne Willems, Gaetan Vanstraelen, Marie Lejeune, Koen Theunissen, Georges Fillet, Frederic Baron

Blood (2008) 112 (11): 54.

https://doi.org/10.1182/blood.V112.11.54.54

Published: 2008

Journal Articles

Diffuse Large B-Cell Lymphomas of the Waldeyer’s Ring Frequently Have a Germinal Center-Like Phenotype: A Clinico-Pathological Study of 209 Patients from the Groupe d’Etude des Lymphomes de L’Adulte (GELA).

Laurence de Leval, MD, Christophe Bonnet, MD, Christiane Copie-Bergman, MD, Laurence Seidel, PhD, Josette Brière, MD, Thierry Molina, MD, Bettina Fabiani, MD, Brunangelo Falini, MD, Christian Gisselbrecht, MD, Hervé Thilly, MD, Adelin Albert, PhD, Georges Fillet, MD, Philippe Gaulard, MD

Blood (2007) 110 (11): 1561.

https://doi.org/10.1182/blood.V110.11.1561.1561

Published: 2007

Journal Articles

Low-Dose Total Body Irradiation (TBI) Followed by Donor Lymphocyte Infusion Increases Donor T-Cell Chimerism Levels in Patients with Low Donor T-Cell Chimerism after Nonmyeloablative Conditioning.

Frederic Baron, E. Willems, E. Baudoux, N. Wanten, M.T. Closon, N. Witvrouw, K. Hafraoui, P. Frere, Georges Fillet, Yves Beguin

Blood (2006) 108 (11): 2961.

https://doi.org/10.1182/blood.V108.11.2961.2961

Published: 2006

Journal Articles

High Dose (HD-AraC) vs Standard Dose Cytosine Arabinoside (SD-AraC) during Induction in Acute Myelogenous Leukemia (AML): Impact on Stem Cell Mobilization after Consolidation and on Autologous Transplantation (Second Report of the EORTC-Leukemia Group (LG) - GIMEMA AML-12 Trial.

Blood (2006) 108 (11): 609.

https://doi.org/10.1182/blood.V108.11.609.609

Published: 2006

Journal Articles

High Dose Cytosine Arabinoside (HD-AraC) vs Standard Dose AraC (SD-AraC) during Induction, and Stem Cell Transplantation Followed by IL-2 or No Maintenance in Acute Myelogenous Leukemia (AML): First Report on the AML-12 Phase III Trial of the EORTC-Leukemia Group (LG) and GIMEMA.

Blood (2005) 106 (11): 271.

https://doi.org/10.1182/blood.V106.11.271.271

Published: 2005

Journal Articles

Dexamethasone Versus Methyl-Prednisolone in Induction Therapy for Adult Acute Lymphoblastic (ALL) and Non-Hodgkin Lymphoma (NHL) Patients ≤ 60 Yrs Old: Final Results of the Eortc All-4 Phase III Trial.

Boris Labar, MD, PhD, Stefan Suciu, PhD, Petra Muus, MD, Roelof Willemze, MD, PhD, Jean-Pierre Marie, MD, Georges Fillet, MD, Zwi Berneman, MD, Branimir Jaksic, MDPhD, Walter Feremans, MD, Dominique Bron, MD, Henry Sinnige, MD, Martin Mistrik, MD, G. Vreugdenhil, MD, Robrecht De Bock, MD, Damir Nemet, MD, Caroline Gilotay, Theo de Witte, MDPhD, Sergio Amadori, MD

Blood (2005) 106 (11): 1834.

https://doi.org/10.1182/blood.V106.11.1834.1834

Published: 2005

Journal Articles

Thrombotic Microangiopathy™ after Allogeneic Peripheral Blood Stem Cell Transplantation with Nonmyeloablative Conditioning (NMSCT) Compared with Myeloablative Conditioning (MSCT).

Evelyne Willems, MD, Frédéric Baron, MD, PhD, Georges Fillet, MD, PhD, Yves Beguin, MD, PhD

Blood (2005) 106 (11): 1774.

https://doi.org/10.1182/blood.V106.11.1774.1774

Published: 2005

Journal Articles

No Role for Chemoradiotherapy When Compared with Chemotherapy Alone in Elderly Patients with Localized Low Risk Aggressive Lymphoma: Final Results of the LNH93-4 GELA Study.

Georges Fillet, C. Bonnet, N. Mounier, G. Ganem, T. Molina, C. Thieblemont, C. Fermé, B. Quesnel, C. Martin, C. Gisselbrecht, H. Tilly, F. Reyes

Blood (2005) 106 (11): 15.

https://doi.org/10.1182/blood.V106.11.15.15

Published: 2005

Journal Articles

Nonmyeloablative Stem Cell Transplantation with CD8-Depleted or Unmanipulated Peripheral Blood Stem Cells: A Prospective Randomized Trial.

Evelyne Willems, MD, Emilie Castermans, Frédéric Baron, MD, PhD, Etienne Baudoux, MD, Nadine Wanten, Christophe Bonnet, MD, Kaoutar Hafraoui, MD, Pascale Frère, MD, Georges Fillet, MD, PhD, Yves Beguin, MD, PhD

Blood (2005) 106 (11): 1075.

https://doi.org/10.1182/blood.V106.11.1075.1075

Published: 2005

Journal Articles

Pegfilgrastrim Compared with Filgrastim after Autologous Hematopoietic Peripheral Blood Stem Cell Transplantation.

Gaetan Vanstraelen, MD, Pascale Frère, MD, Marie-Christine Ngirabacu, MS, Evelyne Willems, MD, Georges Fillet, MD, Yves Beguin, MD

Blood (2005) 106 (11): 5287.

https://doi.org/10.1182/blood.V106.11.5287.5287

Published: 2005

Journal Articles

Infections after CD34-Selected or Unmanipulated Autologous Hematopoietic Stem Cell Transplantation.

Pascale Frère, MD, Maguy Pereira, RN, Georges Fillet, MD, PhD, Yves Beguin, MD, PhD

Blood (2004) 104 (11): 5085.

https://doi.org/10.1182/blood.V104.11.5085.5085

Published: 2004

Journal Articles

Infections after Allogeneic Hematopoietic Stem Cell Transplantation with a Nonmyeloablative Conditioning Regimen.

Pascale Frère, MD, Frédéric Baron, MD, Christoffe Bonnet, MD, Kaoutar Hafraoui, MD, Maguy Pereira, RN, Evelyne Willems, MD, Georges Fillet, MD, PhD, Yves Beguin, MD, PhD

Blood (2004) 104 (11): 5086.

https://doi.org/10.1182/blood.V104.11.5086.5086

Published: 2004

Journal Articles

Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma

Hervé Tilly, Eric Lepage, Bertrand Coiffier, Michel Blanc, Raoul Herbrecht, André Bosly, Michel Attal, Georges Fillet, Catherine Guettier, Thierry Jo Molina, Christian Gisselbrecht, Félix Reyes, for the Groupe d'Etude des Lymphomes de l'Adulte

Blood (2003) 102 (13): 4284–4289.

https://doi.org/10.1182/blood-2003-02-0542

Published: 2003

Journal Articles

Cessation of intensive treatment with recombinant human erythropoietin is followed by secondary anemia

Maude Piron, Martine Loo, André Gothot, Françoise Tassin, Georges Fillet, Yves Beguin

Blood (2001) 97 (2): 442–448.

https://doi.org/10.1182/blood.V97.2.442

Published: 2001

NARROW

Long-Term Safety Follow-up of a Randomized Trial of Darbepoetin Alpha and Intravenous Iron Following Autologous Hematopoietic Cell Transplantation

Darbepoetin-Alfa and I.V. Iron Administration after Autologous Hematopoietic Stem Cell Transplantation: A Prospective Randomized Multicenter Trial

Diffuse Large B-Cell Lymphomas of the Waldeyer’s Ring Frequently Have a Germinal Center-Like Phenotype: A Clinico-Pathological Study of 209 Patients from the Groupe d’Etude des Lymphomes de L’Adulte (GELA).

Low-Dose Total Body Irradiation (TBI) Followed by Donor Lymphocyte Infusion Increases Donor T-Cell Chimerism Levels in Patients with Low Donor T-Cell Chimerism after Nonmyeloablative Conditioning.

High Dose (HD-AraC) vs Standard Dose Cytosine Arabinoside (SD-AraC) during Induction in Acute Myelogenous Leukemia (AML): Impact on Stem Cell Mobilization after Consolidation and on Autologous Transplantation (Second Report of the EORTC-Leukemia Group (LG) - GIMEMA AML-12 Trial.

High Dose Cytosine Arabinoside (HD-AraC) vs Standard Dose AraC (SD-AraC) during Induction, and Stem Cell Transplantation Followed by IL-2 or No Maintenance in Acute Myelogenous Leukemia (AML): First Report on the AML-12 Phase III Trial of the EORTC-Leukemia Group (LG) and GIMEMA.

Dexamethasone Versus Methyl-Prednisolone in Induction Therapy for Adult Acute Lymphoblastic (ALL) and Non-Hodgkin Lymphoma (NHL) Patients ≤ 60 Yrs Old: Final Results of the Eortc All-4 Phase III Trial.

Thrombotic Microangiopathy™ after Allogeneic Peripheral Blood Stem Cell Transplantation with Nonmyeloablative Conditioning (NMSCT) Compared with Myeloablative Conditioning (MSCT).

No Role for Chemoradiotherapy When Compared with Chemotherapy Alone in Elderly Patients with Localized Low Risk Aggressive Lymphoma: Final Results of the LNH93-4 GELA Study.

Nonmyeloablative Stem Cell Transplantation with CD8-Depleted or Unmanipulated Peripheral Blood Stem Cells: A Prospective Randomized Trial.

Pegfilgrastrim Compared with Filgrastim after Autologous Hematopoietic Peripheral Blood Stem Cell Transplantation.

Infections after CD34-Selected or Unmanipulated Autologous Hematopoietic Stem Cell Transplantation.

Infections after Allogeneic Hematopoietic Stem Cell Transplantation with a Nonmyeloablative Conditioning Regimen.

Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma

Cessation of intensive treatment with recombinant human erythropoietin is followed by secondary anemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only